Seokho Yoon Net Worth

Seokho Yoon biography

Mr. Seokho Bryan Yoon Esq. is no longer serves as Chief Administrative Officer, General Counsel and Corporate Secretary of the Company effective 11/6/2020. is no longer serves as Chief Administrative Officer, General Counsel and Corporate Secretary of the Company effective 11/6/2020. Mr. Yoon was most recently the General Counsel and Secretary at Nightstar Therapeutics plc, a gene therapy company focused on inherited retinal diseases, from November 2017 until its acquisition by Biogen in June 2019. At Nightstar, he was responsible for the legal, compliance and intellectual property functions, in addition to leading all human resources activities, through a period of significant growth. Prior to Nightstar, Mr. Yoon worked at Intercept Pharmaceuticals, Inc., a leading biopharmaceutical company focusing on nonviral liver diseases, from January 2013 until November 2017, where he most recently served as Senior Vice President—Legal Affairs and Secretary. Previously, Mr. Yoon worked at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C. and Simpson Thacher & Bartlett LLP, where he advised clients, including a number of life sciences companies, on a variety of corporate and other legal matters. Mr. Yoon holds a B.A. in Economics and an M.Eng. in Operations Research and Industrial Engineering from Cornell University. He received his J.D. from the University of Michigan Law School.

What is the salary of Seokho Yoon?

As the of ContextLogic Inc, the total compensation of Seokho Yoon at ContextLogic Inc is $665,742. There are 1 executives at ContextLogic Inc getting paid more, with Frederic Chereau M.B.A. having the highest compensation of $677,202.

How old is Seokho Yoon?

Seokho Yoon is 42, he's been the of ContextLogic Inc since . There are 14 older and 3 younger executives at ContextLogic Inc. The oldest executive at ContextLogic Inc is Richard Moscicki, 68, who is the Independent Director.

What's Seokho Yoon's mailing address?

Seokho's mailing address filed with the SEC is 203 Crescent St Ste 303, Waltham, MA 02453, USA.

Insiders trading at ContextLogic Inc

Over the last 6 years, insiders at ContextLogic Inc have traded over $4,601,420 worth of ContextLogic Inc stock and bought 6,882,964 units worth $56,977,784 . The most active insiders traders include Tomer Kariv, Advisors Llc Orbi Med Capit... a Mark J Enyedy. On average, ContextLogic Inc executives and independent directors trade stock every 97 days with the average trade being worth of $1,869,237. The most recent stock trade was executed by Brett Just on 15 August 2024, trading 6,465 units of LOGC stock currently worth $34,588.

What does ContextLogic Inc do?

wish is a mobile e-commerce platform that connects hundreds of millions of consumers with the widest selection of products delivered directly to their doors. our mission is to provide everyone access to the most affordable and convenient shopping experience on the planet. wish supports 500,000 merchant partners as well as over 300 million users who rate wish the best mobile shopping app on the ios and android platforms. founded in 2011, wish has raised over a billion dollars from top funds, such as temasek, dst, ggv capital, founders fund, and jerry yang’s ame cloud. wish is headquartered in san francisco, with additional offices in shanghai, toronto, dublin, amsterdam, and more.

ContextLogic Inc executives and stock owners

ContextLogic Inc executives and other stock owners filed with the SEC include:

• Frederic Chereau M.B.A.,
  Pres, CEO & Director
• Seokho Yoon,
  
• Frederic Chereau,
  President, Chief Executive Officer, Director
• Dr. Daniel J. Gruskin M.D.,
  Chief Medical Officer
• Mariana Nacht Ph.D.,
  Chief Scientific Officer
• Mark Kay,
  Independent Director
• Dr. Mark A. Kay M.D., Ph.D.,
  Co-Founder, Chairman of Scientific Advisory Board & Independent Director
• Michael Wyzga,
  Independent Director
• Erez Chimovits,
  Independent Director
• Leon Chen,
  Independent Director
• Richard Moscicki,
  Independent Director
• Daniel O'Connell,
  Independent Director
• Kyle Chiang,
  Chief Operating Officer
• Daniel Gruskin,
  Interim Head of Clinical Development
• Brian Luque,
  Associate Director, Investor Relations
• Mark Enyedy,
  Independent Director
• Matthias Jaffe,
  Chief Financial Officer
• Grace Lochhead,
  VP & Head of HR
• Dr. Leszek Lisowski M.B.A., Ph.D.,
  Co-Founder & Member of Scientific Advisory Board
• Matthias B. Jaffe,
  Consultant
• Andrea Paul,
  Gen. Counsel & Corp. Sec.
• Dr. Matthias Hebben,
  Global VP & Head of Technology Devel.
• Cecilia Jones,
  Chief Financial Officer
• Dr. Adi Barzel Ph.D.,
  Co-Founder
• Dr. Leszek Lisowski Ph.D.,
  Co-Founder
• Mariana Nacht,
  Chief Scientific Officer
• Brett Just,
  Chief Financial Officer
• Bioscience Plc Arix Bioscie...,
  
• Tomer Kariv,
  Director
• Sofia Ioannidou,
  Director
• Thomas Wilton,
  Chief Business Officer
• Dean Falb,
  Chief Scientific Officer
• Advisors Llc Orbi Med Capit...,
  
• Kenneth Huttner,
  SVP, Head of Clinical Dev.
• Advisors Llc Orbi Med Capit...,
  
• Cecilia Jones,
  Chief Financial Officer
• Daphne Karydas,
  Director
• Jeff Goater,
  Director
• Susan Kahn,
  Director
• Andrea Paul,
  General Counsel and Secretary
• Joanna Forster,
  General Counsel & CCO